Merck & (MRK) Revenue — Quarter Ended Dec 31, 2023
Revenue for the current quarter declined compared to the prior quarter but increased compared to the same quarter last year. The company's operating cash flow was reduced by significant collaboration payments and a legal settlement.
Key takeaway
Quarter ended Dec 31, 2023 · FY2023 Q4
Revenue for the current quarter declined compared to the prior quarter but increased compared to the same quarter last year. The company's operating cash flow was reduced by significant collaboration payments and a legal settlement.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$14.6B
Revenue reported for this quarter.
Quarter-over-quarter
-8.3%
Change from the immediately preceding quarter.
Year-over-year
+5.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$60.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2023 | $14.5B | -8.9% |
| Jun 30, 2023 | $15B | +3.0% |
| Sep 30, 2023 | $16B | +6.7% |
| Dec 31, 2023 | $14.6B | +5.8% |
Revenue performance
The reported revenue shows a sequential decline, while still posting year-over-year growth.
Quarterly comparison
Compared to the immediately preceding quarter, revenue was lower. However, compared to the same quarter one year earlier, revenue was higher.
What to watch
The impact of collaboration payments and a legal settlement on operating cash flow may be a factor to monitor in upcoming periods.